Targeting Hypoxia: Revival of Old Remedies
Tumour hypoxia is significantly correlated with patient survival and treatment outcomes. At the molecular level, hypoxia is a major driving factor for tumour progression and aggressiveness. Despite the accumulative scientific and clinical efforts to target hypoxia, there is still a need to find spec...
Main Authors: | Nuria Vilaplana-Lopera, Maxym Besh, Eui Jung Moon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/11/1604 |
Similar Items
-
Targeting hypoxia: Revival of old remedies
by: Vilaplana-Lopera, N, et al.
Published: (2021) -
DNA Damage Measured by the Comet Assay in Head and Neck Cancer Patients Treated with Tirapazamine
by: Mary Jo Dorie, et al.
Published: (1999-11-01) -
Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice
by: Yongchuan Gu, et al.
Published: (2017-08-01) -
Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers
by: Giimel Ajnai, et al.
Published: (2022-04-01) -
Studies related to the enhanced the effect of 5-aminolevulinic acid-based photodynamic therapy combined with tirapazamine
by: Qian Wang, et al.
Published: (2024-10-01)